- Market cap
- Revenue
- Net income
- Cash on hand
- Gross margin
- Net margin
- EPS
- P/E ratio
PLAINVIEW, N.Y., May 15, 2026 (GLOBE NEWSWIRE) — Vaso Corporation (“Vaso”) (OTCQX: VASO), a leading MedTech company with a diversified business portfolio in network and IT services, professional sales services, and proprietary medical products, today announced its operating results for the three months ended March 31, 2026. “For the first quarter of 2026, the Company The post Vaso Corporation Announces Financial Results for First Quarter of 2026 appeared first on .
PLAINVIEW, N.Y., March 31, 2026 — Vaso Corporation (“Vaso”) (OTCQX: VASO), a leading MedTech company with a diversified business portfolio in network and IT services, professional sales services, and proprietary medical products, today announced its operating results for the three months and year ended December 31, 2025. “The Company’s annual revenue reached a record $89.1 million The post Vaso Corporation Announces Financial Results for Fourth Quarter and Full Year 2025 appeared first on .
PLAINVIEW, N.Y., Dec. 17, 2025 (GLOBE NEWSWIRE) — Vaso Corporation (OTCQX: VASO) announced today that its wholly owned subsidiary, Vaso Diagnostics, Inc. d/b/a VasoHealthcare, has signed an amendment to the sales representation agreement with GE HealthCare (NASDAQ: GEHC) to extend the term of the agreement through December 31, 2030. This is the fifth time the parties The post Vaso Corporation Announces Fifth Extension of Sales Representation Agreement with GE HealthCare appeared first on .
PLAINVIEW, N.Y, Nov. 19, 2025 — Vaso Corporation (“Vaso”) (OTCQX: VASO), a leading MedTech company with a diversified business portfolio in network and healthcare IT services, professional sales services and proprietary medical products, announced today that it had reached an agreement, subject to certain conditions, with Nano-X Imaging Ltd. (“Nanox”) (Nasdaq: NNOX), an innovative medical imaging The post Vaso Corporation Announces Divestiture of Subsidiary appeared first on .
PLAINVIEW, N.Y., Nov. 14, 2025 — Vaso Corporation (“Vaso”) (OTCQX: VASO), a leading MedTech company with a diversified business portfolio in network and healthcare IT services, professional sales services and proprietary medical products, today announced operating results for the three months ended September 30, 2025. “For the third quarter of 2025, the Company’s total revenue The post Vaso Corporation Announces Financial Results for Third Quarter of 2025 appeared first on .
PLAINVIEW, N.Y., Aug. 14, 2025 — Vaso Corporation (“Vaso”) (OTCQX: VASO), a leading MedTech company with a diversified business portfolio in network and healthcare IT services, professional sales services and proprietary medical products, today announced operating results for the three months ended June 30, 2025. “The Company’s 2025 second quarter revenue was $20.0 million, slightly The post Vaso Corporation Announces Financial Results for Second Quarter of 2025 appeared first on .
PLAINVIEW, N.Y., May 15, 2025 — Vaso Corporation (“Vaso”) (OTCQX: VASO), a leading MedTech company with a diversified business portfolio in network and healthcare IT services, professional sales services, and proprietary medical products, today announced its operating results for the three months ended March 31, 2025. “The Company recorded record first quarter revenue, with revenue The post Vaso Corporation Announces Financial Results for First Quarter of 2025 appeared first on .
The Company Reports Continued Growth in Annual Revenue PLAINVIEW, N.Y., March 31, 2025 — Vaso Corporation (“Vaso”) (OTCQX: VASO), a leading MedTech company with a diversified business portfolio in network and healthcare IT services, professional sales services, and proprietary medical products, today announced its operating results for the three months and year ended December 31, 2024. The post Vaso Corporation Announces Financial Results for Fourth Quarter and Full Year 2024 appeared first on .
PLAINVIEW, N.Y. January 13, 2025 – Vaso Corporation (“Vaso”) (OTCQX: VASO), a leader in human capital, information technology and MedTech, today announced new executive appointments to the Vaso management team and Board of Directors, effective January 1, 2025. Furthermore, Vaso Corporation named new corporate and securities outside counsel, Kimberly Decker of the law firm Barley The post Vaso Corporation Announces Executive Leadership Appointments & Names New Vice Chairman to the Board of Directors appeared first on .
Plainview, N.Y. December 16, 2024 – Vaso Corporation (“Vaso”) (OTCQX: VASO), a leader in human capital, information technology and MedTech, today released a letter to shareholders and employees summarizing the company’s achievements throughout the year and outlining key strategic developments and priorities for the upcoming year.  Highlights in the letter include operational developments, product updates, The post Vaso Corporation CEO Reflects on a Year of Growth and Innovation in End-of-Year Letter Setting the Tone for a Promising 2025 appeared first on .
